维普中文期刊产品整合服务
15篇 您的检索式:作者名="Karlsson RM"
    题名 作者 年代 出处 被引量
1Galanin as a modulator of anxiety and depression and a therapeutic target for affective disease显示文摘Karlsson RM Holmes A 2006Amino Acids2006,31,3:1
2The neuropeptide Y YI receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice 显示文摘Karlsson RM Choe JS Cameron HA 2008Psychopharmacology2008,195,4:1
3Association of mouse Dlg4 (Psd-95) gene deletion and human Dlg4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome显示文摘Feyder M Karlsson RM Mathur P 2010Am J Psychiatry2010,167,12:1
4Exaggerated cue-induced reinstatement of cocaine seeking but not incubation of cocaine craving in a developmental rat model of schizophrenia 显示文摘Karlsson RM Kircher DM Shaham Y 2013Psychopharmacology (Bed)2013,226,1:1
5Anxiolytic-like actions of centrally-administered neuropeptide Y,but not galanin,in C57BL/6J mice显示文摘Karlsson RM Holmes A Heilig M 2005Pharmacol Biochem Behav2005,80,3:1
6Diagnosing model diag nostics显示文摘Karlsson MO Savic RM 2007Clin Pharmacol Ther2007,82,1:1
7Identification of a receptor required for the anti-inflammatory activity of IVIG显示文摘Anthony RM Wermeling F Karlsson MC 0,,:1
8Diagnosing model diagnostics 显示文摘Karlsson MO Savic RM 2007Clin Pharmacol Ther2007,82,:1
9The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide y, but not the antidepressant-like effects of fluoxetine in mice显示文摘Karlsson RM ChoeJS Cameron HA 2008Psychopharmacology (Berl)2008,195,4:1
10Effects of antioxidant pretreatment on the survival of embryonic dopaminergic neurons in vitro and following grafting in an animal model of Parkinson's disease显示文摘Love RM Branton RL Karlsson J 2002Cell Transplant2002,11,7:1
11Identification of a receptor required for the anti-inflammatory activity of IVIG显示文摘Anthony RM Wermeling F Karlsson MC 2008Proc Natl Acad Sci USA2008,105,19:1
12Population pharmacokinetics of rifampin in pulmonary tuberculosis patients,including a semimechanistic model to describe variable absorption显示文摘Wilkins JJ Savic RM Karlsson MO 2008Antimicrob Agents Chemother2008,52,6:1
13Diagnosing model diagnostics显示文摘Karlsson MO Savic RM 2007Clin Pharmacol Ther2007,82,:1
14Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice显示文摘Karlsson RM Hohnes A Heilig M 2005Pharmacol Biochem Behav2005,80,3:1
15Maraviroc for previously treated patients with R5 HIV-1 infection 显示文摘Gulick RM Lalezari J Goodrich J Clumeck N DeJesus E Horban A Nadler J Clotet B Karlsson A Wohlfeiler M Montana JB McHale M Sullivan J Ridgway C Fel-stead S Dunne MW van der Ryst E Mayer H 2008N Engl J Med2008,359,14:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费